Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society.
Faconti L, Kulkarni S, Delles C, Kapil V, Lewis P, Glover M, MacDonald TM, Wilkinson IB.
J Hum Hypertens. 2024 Jan;38(1):8-18. doi: 10.1038/s41371-023-00875-1. Epub 2023 Nov 14.
Diagnosis of primary hyperaldosteronism.
Araujo-Castro M, Parra-Ramírez P.
Med Clin (Barc). 2022 May 13;158(9):424-430. doi: 10.1016/j.medcli.2021.10.012. Epub 2021 Dec 16.
Primary aldosteronism - a multidimensional syndrome.
Turcu AF, Yang J, Vaidya A.
Nat Rev Endocrinol. 2022 Nov;18(11):665-682. doi: 10.1038/s41574-022-00730-2. Epub 2022 Aug 31.
Redefining primary hyperaldosteronism as "The Syndrome of Inappropriate Aldosterone Secretion (SIALDS)": A common but unrecognized cause of hypertension.
Lamba R.
J Clin Hypertens (Greenwich). 2023 Dec;25(12):1045-1052. doi: 10.1111/jch.14740. Epub 2023 Oct 25.
Hyperaldosteronism as a common cause of resistant hypertension.
Calhoun DA.
Annu Rev Med. 2013;64:233-47. doi: 10.1146/annurev-med-042711-135929. Epub 2012 Oct 22.
Primary Aldosteronism: JACC State-of-the-Art Review.
Rossi GP.
J Am Coll Cardiol. 2019 Dec 3;74(22):2799-2811. doi: 10.1016/j.jacc.2019.09.057.
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Vaidya A, Carey RM.
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3771-83. doi: 10.1210/clinem/dgaa606.
Primary aldosteronism in pregnancy.
Forestiero V, Sconfienza E, Mulatero P, Monticone S.
Rev Endocr Metab Disord. 2023 Feb;24(1):39-48. doi: 10.1007/s11154-022-09729-6. Epub 2022 May 10.
What We Know about and What Is New in Primary Aldosteronism.
Ekman N, Grossman AB, Dworakowska D.
Int J Mol Sci. 2024 Jan 11;25(2):900. doi: 10.3390/ijms25020900.
Clinical Management of Primary Aldosteronism: An Update.
Rossi GP, Rossi FB, Guarnieri C, Rossitto G, Seccia TM.
Hypertension. 2024 Sep;81(9):1845-1856. doi: 10.1161/HYPERTENSIONAHA.124.22642. Epub 2024 Jul 24.
